Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Laboratorios Farmacéuticos Rovi, S.A. has announced a modification to the securities and cash balances of its Liquidity Contract with Bestinver SV, S.A. Following the adjustment, the securities account will contain 6,000 shares, and the cash balance will stand at 570,000 euros.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue